Month: August 2021

       Ageas announces new share buy-back programme Ageas announces the decision of the Board of Directors to initiate a new share buy-back programme of its outstanding common stock for an amount of EUR 150 million. This follows the shareholders’ authorisation granted in May 2021. The share buy-back programme will start on 1 September 2021 and will run up to 29 July 2022. This programme, which is in line with the Group’s financial targets under the Connect21 strategy, will be implemented in accordance with industry best practices and in compliance with the applicable buy-back rules and regulations. To this end, Ageas will mandate an independent broker to execute the programme through open market purchases on its behalf on Euronext Brussels. The bought back shares will be held as treasury shares. Ageas intends to propose to its shareholders...

MARSEILLE, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as of August 1, 2021:Total number of shares outstanding: 79,164,402 ordinary shares     6,784 Preferred Shares 2016      7,581 Preferred Shares 2017   Total number of theoretical voting rights (1): 79,957,342   Total number of exercisable voting rights (2): 79,938,767  (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing...

Marseille, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as of August 1, 2021:  Total number of shares outstanding: 79,164,402 ordinary shares  6,784 Preferred Shares 2016 7,581 Preferred Shares 2017Total number of theoretical voting rights (1): Total number of exercisable voting rights (2): 79,957,342 79,938,767  (1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds....

The net asset value (NAV) of EfTEN Real Estate Fund III AS as of 31.07.2021 was 17,747 euros. The net asset value of the EPRA share (net book value excluding deferred income tax liability and fair value of interest rate derivatives) as of 31.07.2021 was 18.75 euros. Both NAV and EPRA NAV increased by 0.8% in July. In July, the consolidated sales revenue of EfTEN Real Estate Fund III AS amounted to 1,146 thousand euros, which is 49 thousand euros more than in June – in July, for the first time, the full-month rental income of the last acquisition of the fund, the warehouse and industrial building complex in Panevezys was added, and in addition, the sales revenues of the Saules Miestas shopping center increased by 15 thousand euros. The Fund’s consolidated EBITDA was 978 thousand euros in July, which is 150 thousand euros higher...

ABN AMRO reports net profit of EUR 393 million in Q2 2021Operating performance in line with previous quarters; net impairment release of EUR 79 million Return on equity of 7.6% in spite of continued pressure on net interest income and incidentals Society gradually opening up; Dutch economy holding up well as government support continues Well ahead of plan in CIB non-core wind–down; over 80% reduction, supported by loan disposals Full-year cost of risk expected to be well below the through-the-cycle guidance of 25-30 bps Very strong capital position, Basel CET1 ratio of 18.3% (Basel IV around 16%) Final 2019 dividend of EUR 0.68 per share to be paid in October 2021 Making progress in executing our strategy to be a personal bank in the digital ageRobert Swaak, CEO, comments: ‘Society is gradually opening up as vaccination programmes...

Coop Pank’s financial results in July 2021:In July, number of the bank’s clients increased by 2,100 and reached 102,300 by the end of the month. Over the year, customer base has grown by 34%. Volume of the bank’s customer deposits increased by 2 million euros, reaching 893 million euros by the end of month. Deposits of corporate customers increased by 27 million and deposits of private customers by 3 million. The volume of deposits attracted from international platforms and other financing decreased by 28 million euros. Over the year, volume of bank deposits has grown by 37%.       The bank’s loan portfolio increased by 22 million euros over the month and reached 794 million euros by the end of July. Over the year, loan portfolio has grown by 39%. Compared to the first seven months of last year, the bank’s net...

All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Cannabis Science Inc., formerly known as (CBIS) per its previous trading history on the OTC Markets Exchange, is very pleased to announce it has just successfully launched its $CSI Cannabis Science Coin, Utility for CSi-EDP project asset valuation, revenue tracking, and dividend disbursements.  As well, the CSi-EDP will use the $CSI Cannabis Science Coin for several of its transaction-based products and services. Each Cannabis Science CSi-EDP product and or service assigned will become a part of the $CSI Cannabis Science Coin investment banking and economic development ecosystem, thus multiplying the $CSI Cannabis Science Coin value and International reach! Over...

SALT LAKE CITY, Aug. 10, 2021 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an additional 636,792 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares to be sold in the offering are being...

TORONTO, Aug. 10, 2021 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, today announced that its second quarter 2021 results for the three months ended June 30, 2021 will be released on Monday August 16, 2021 after the close of market. MCI will host a conference call and webcast on the same day at 5:30 pm (EDT) to discuss the financial results and progress towards its key strategic initiatives. The call will be hosted by Dr. Alexander Dobranowski, Chief Executive Officer; Scott Nirenberski, Chief Financial Officer and Fernando Massalin, Investor Relations. Please dial in 10 minutes prior to the start of the call. Conference Call DetailsDate:Time:Duration:   Monday August 16, 20215:30 pm (EDT)60 minutes     Dial-in...